Literature DB >> 29501284

Analysis of causality from observational studies and its application in clinical research in Intensive Care Medicine.

C Coscia Requena1, A Muriel2, O Peñuelas3.   

Abstract

Random allocation of treatment or intervention is the key feature of clinical trials and divides patients into treatment groups that are approximately balanced for baseline, and therefore comparable covariates except for the variable treatment of the study. However, in observational studies, where treatment allocation is not random, patients in the treatment and control groups often differ in covariates that are related to intervention variables. These imbalances in covariates can lead to biased estimates of the treatment effect. However, randomized clinical trials are sometimes not feasible for ethical, logistical, economic or other reasons. To resolve these situations, interest in the field of clinical research has grown in designing studies that are most similar to randomized experiments using observational (i.e. non-random) data. Observational studies using propensity score analysis methods have been increasing in the scientific papers of Intensive Care. Propensity score analyses attempt to control for confounding in non-experimental studies by adjusting for the likelihood that a given patient is exposed. However, studies with propensity indexes may be confusing, and intensivists are not familiar with this methodology and may not fully understand the importance of this technique. The objectives of this review are: to describe the fundamentals of propensity index methods; to present the techniques to adequately evaluate propensity index models; to discuss the advantages and disadvantages of these techniques.
Copyright © 2018 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  Causalidad; Causality; Clinical trial; Confounders; Confusión; Cuidados Intensivos; Ensayo clínico; Epidemiology; Epidemiología; Estudio observacional; Intensive Care; Observational study; Propensity score; Propensión

Mesh:

Year:  2018        PMID: 29501284     DOI: 10.1016/j.medin.2018.01.002

Source DB:  PubMed          Journal:  Med Intensiva (Engl Ed)        ISSN: 2173-5727


  3 in total

1.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

2.  Matched cohort study on the efficacy of tocilizumab in patients with COVID-19.

Authors:  Alejandro Rodríguez-Molinero; Carlos Pérez-López; César Gálvez-Barrón; Antonio Miñarro; Oscar Macho; Gabriela F López; Maria Teresa Robles; Maria Dolores Dapena; Sergi Martínez; Ezequiel Rodríguez; Isabel Collado Pérez
Journal:  One Health       Date:  2021-01-05

Review 3.  Learning Causal Effects From Observational Data in Healthcare: A Review and Summary.

Authors:  Jingpu Shi; Beau Norgeot
Journal:  Front Med (Lausanne)       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.